Loxicom 0.5mg/ml Oral Suspension 30ml for cats
This is a prescription medicine. A prescription is required from your veterinarian before we can supply this product. Please ensure that you have read the "How to Order" page before ordering this item.
All of our products are APVMA or TGA approved and identical to those used by your veterinarian. Please call or email us if you have any queries about any of the products on our site.
|Drug Name and Strength||Meloxicam(0.5mg/mL)|
|Indication||Alleviation of inflammation and pain in acute and chronic musculoskeletal disorders such as discospondylosis, arthropathy and soft tissue injuries.|
|Contraindications||Do not use in animals with cardiac, hepatic or clinical renal disease. Do not use in pregnant or lactating animals as no data has been established for them.|
|Actions||Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, exerting anti-inflammatory, antiexudative, analgesic and antipyretic effects. It reduces leukocyte infiltration into the inflamed tissue and prevents bone and cartilage damage. To a minor extent, it also inhibits collagen induced thrombocyte aggregation.|
|Precautions||Older cats considered for ongoing treatment should be screened for pre-existing renal, hepatic or gastrointestinal disorders or hypovolaemia (using haematological tests, serum biochemical analysis and urinalysis as necessary) before administration. This is also the case when there is the possibility of gastrointestinal ulceration or bleeding, or when there is evidence of a haemorrhagic disorder or individual hypersensitivity to the product.As for all NSAIDs, use in any animal less than 6 weeks of age or in debilitated aged animals may involve additional risk. If use in such animals cannot be avoided, careful clinical management may be required.Do not administer concurrently with steroidal drugs or other NSAIDs, aminoglycoside antibiotics or anticoagulant agents. Concurrent administration of potentially nephrotoxic drugs should be avoided.Pretreatment with anti-inflammatory drugs may result in additional or increased adverse effects, so a treatment free period with such drugs should be observed for at least 24 hours before initiating treatment with Loxicom 0.5 mg/mL Oral Suspension. The treatment free period should take into account the pharmacokinetic properties of the drugs used previously.Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk for renal toxicity.Response to long-term therapy should be monitored at three monthly intervals or more frequently as advised by the veterinarian. Regular monitoring of older cats undergoing long-term therapy is particularly important.Loxicom 0.5 mg/mL Oral Suspension for Cats should not be used after parenteral injection of Loxicom or any other NSAID, as appropriate dosage regimens for such followup treatments have not been established.First Aid If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131 126.Disposal Dispose of empty container by wrapping with paper and putting in garbage.|
|Dosage and Administration||Shake well before use. Should be administered orally either mixed with food or directly into the mouth around meal times. Clean and dry measuring syringes after each use. Initial dose. On the first day of treatment, a single dose of 0.1 mg/kg bodyweight should be given. Maintenance dose. Treatment is to be continued once daily by oral administration (at 24 hour intervals) at a maintenance dose of meloxicam 0.05 mg/kg bodyweight. Particular care should be taken with the accuracy and timing of dosing. The recommended dose should not be exceeded. Ensure dose is delivered at the same time each day.A clinical response is normally seen within seven days. Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent.|
|Storage||Store below 25°C (air conditioning). Discard six months after initial use.|
|MSDS (external link)||Not specified|
|Manufacturer||Norbrook Laboratories Australia P/L|